Interleukin-22 Ameliorates Dextran Sulfate Sodium-Induced Colitis through the Upregulation of lncRNA-UCL to Accelerate Claudin-1 Expression via Sequestering miR-568 in Mice

BACKGROUND: Bioactive compound such as interleukin-22 (IL-22) treatment is regarded as a sufficient treatment for ulcerative colitis (UC). It has been found that long noncoding RNAs (lncRNAs) expressed in many inflammatory diseases, including UC. We aimed to verify the treatment effect of bioactive...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Chonghua, Chen, Zehan, Huang, Jialan, Gan, Riyun, Wang, Jianyao, Wang, Lisheng, Li, Defeng, Yao, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453001/
https://www.ncbi.nlm.nih.gov/pubmed/36092152
http://dx.doi.org/10.1155/2022/8543720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453001/
https://www.ncbi.nlm.nih.gov/pubmed/36092152
http://dx.doi.org/10.1155/2022/8543720

Ejemplares similares